HTC
RPTX

Hershey Trust Company’s Repare Therapeutics RPTX Stock Holding History

Hershey Trust Company’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,883
Closed -$62.2K – 8
2023
Q2 		$62.2K Buy
+5,883
New +$60.6K ﹤0.01% 7
2022
Q3 		– Sell
-12,829
Closed -$179K – 29
2022
Q2 		$179K Buy
+12,829
New +$151K ﹤0.01% 24
2021
Q3 		– Sell
-24,728
Closed -$771K – 41
2021
Q2 		$771K Sell
24,728
-4,831
-16% -$158K 0.01% 16
2021
Q1 		$907K Buy
29,559
+21,962
+289% +$746K 0.01% 15
2020
Q4 		$261K Buy
+7,597
New +$227K ﹤0.01% 23

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Hershey Trust Company's RPTX Position: Q3 2023 in Review

Hershey Trust Company sold out of Repare Therapeutics (RPTX) in Q3 2023, closing a stake of 5,883 shares — an estimated $62.2K sold.

Hershey Trust Company first reported a position in RPTX in Q4 2020 and held it in 5 quarters. The position peaked at $907K in Q1 2021. 76 funds tracked by Wall St. Rank hold RPTX as of Q3 2023.

  • Hershey Trust Company reported no remaining Repare Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Hershey Trust Company sold 5,883 Repare Therapeutics shares in Q3 2023, an estimated $62.2K.
  • Hershey Trust Company first reported a position in Repare Therapeutics in Q4 2020 and held it in 5 quarters.
  • Hershey Trust Company's Repare Therapeutics position peaked at $907K in Q1 2021.
  • 76 funds tracked by Wall St. Rank held Repare Therapeutics as of Q3 2023.

Based on Hershey Trust Company's 13F filing for Q3 2023, filed 14 Nov 2023.